New solutions for AO imaging presented at ARVO
During ARVO 2023 in New Orleans, we were thrilled to present and discuss in person our solutions for cellular-resolution…
ARVO 2023 – rtx1 users present new clinical findings
This year, users of the rtx1 AO cameras will introduce new biomarkers and methods for AO studies, as well as novel clinical…
Visual cell loss revealed in asymptomatic RPGR mutation carriers
An adaptive optics study conducted at the Lions Eye Institute was recently published in Investigative Ophthalmology &…
Many thanks to customers who presented at ISER 2023
Last week at the ISER 2023 biennal meeting, users of Imagine Eyes' retinal imaging devices have shared their work and findings…
Great presentations at the AO-Vision symposium !
Last week, rtx1 users presented their work in IRDs at the AO-vision symposium.
Imagine Eyes appoints Maelys Bellay as QA/RA specialist
Maelys Bellay recently joined our Quality Assurance and Regulatory Affairs (QA/RA) team at Imagine Eyes. “I am happy to…
Adaptive optics monitors photoreceptor response to therapy in multifocal choroiditis
Recently published in Retinal Cases & Brief Reports, a longitudinal case study describes the course of retinal alterations…
Imagine Eyes selected for Bpifrance accelerator program
We are happy to share that Imagine Eyes is laureate for a second accelerator program in less than one year!
This month,…
Imagine Eyes to meet pharmas to speed up the development of therapies
To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…